CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$1.19−0.12 (-9.16%)

Close on Nov 12, 2026Market cap $20.93MP/E –Yield –

Cel Sci statistics

68 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $23.04M; $289.51M
Enterprise Value: $16.51M; $155.84M
PB Ratio: 2.10; 2.13
P/TBV Ratio: 2.12; 2.38

Share statisticsIndustry

Shares Outstanding: 18M; 58M
Shares Change (YoY): 215.5%; 10.9%
Shares Change (QoQ): 107.1%; 0.48%
Float: 17M; 49M
Shares Held by Insiders: 4.17%; 12.1%
Shares Held by Institutions: 11.3%; 56.4%

Short sellingIndustry

Short Interest: 705,801; –
Short Interest Change: 6.32%; -0.80%
Short % of Float: 4.19%; 9.06%
Short % of Shares Outstanding: 4.01%; 6.30%
Days to Cover: 5.96; 5.15

Stock price statisticsIndustry

52-Week High: $7.80; –
52-Week Low: $0.89; –
20-Day Moving Average: $1.51; –
50-Day Moving Average: $1.68; –
200-Day Moving Average: $2.34; –
Average True Range (14): $0.16; –
Price Change (1 Week): -5.07%; -0.58%
Price Change (1 Month): -25.1%; -0.28%
Price Change (3 Months): -12.1%; -17.1%
Price Change (6 Months): 9.17%; -20.1%
Price Change (YTD): -75.1%; -20.1%
Price Change (1 Year): -81.8%; -19.3%
Price Change (3 Years): -98.2%; -22.2%
Price Change (5 Years): -99.6%; -76.4%
Price Change (10 Years): -99.4%; -62.4%
Average Volume (10 Days): 102,018; –
Average Volume (20 Days): 106,297; –
Average Volume (90 Days): 214,294; –
Relative Volume: 0.41; 0.73
Relative Strength Index (14): 38.3; 47.7
Volatility (1 Year): 109.1%; 80.2%
Beta (5 Years): 1.86; 1.08

Returns on capitalIndustry

Return on Equity (ROE): -252.5%; -51.3%
Return on Assets (ROA): -108.9%; -40.7%
Return on Invested Capital (ROIC): -364.5%; -32.9%
Return on Capital Employed (ROCE): -136.9%; -38.1%

Financial positionIndustry

Current Ratio: 1.48; 3.30
Quick Ratio: 1.28; 2.40
Interest Coverage: -50.08; -6.35

EfficiencyIndustry

Profits Per Employee: -$338.86K; -$683.67K
Employee Count: 67; 75
WACC: 14.2%; 10.1%

Income statement (TTM)Industry

Operating Income: -$22.29M; -$20.99M
Net Income: -$22.70M; -$21.61M
EBITDA: -$20.29M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $6.53M; $66.80M
Net Cash (Debt): $6.53M; $16.56M
Net Cash Per Share: $0.37; $0.71
Equity (Book Value): $10.96M; $52.23M
Book Value Per Share: $0.62; $1.50
Tangible Book Value: $10.89M; $26.10M
Working Capital: $2.42M; $78.41M

Cash flow (TTM)Industry

Operating Cash Flow: -$16.75M; -$12.27M
Capital Expenditures: -$5.16K; -$944.00K
Free Cash Flow: -$16.75M; -$18.20M
FCF Per Share: -$0.95; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -98.5%; -20.1%
FCF Yield: -72.7%; -9.14%
Buyback Yield: -110.4%; -0.69%
Shareholder Yield: -110.4%; 0.00%

Taxes and interestIndustry

Interest Expense: $445.00K; $2.98M

Scores and fair valueIndustry

Altman Z-Score: -38.43; 0.31
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	CVM	S&P 500	Difference	CVM per year	S&P 500 per year
1 month	-35.0%	-2.7%	−32.3 pts
3 months	-19.6%	-1.7%	−17.8 pts
Year to date	-77.4%	+11.9%	−89.3 pts
1 year	-82.3%	+12.0%	−94.3 pts
3 years	-98.3%	+78.2%	−176.5 pts	-74.3%	+21.2%
5 years	-99.7%	+73.2%	−172.9 pts	-68.2%	+11.6%
10 years	-99.5%	+309.6%	−409.1 pts	-40.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CVM shares were sold short on Oct 30, 2026, up 6.3% from the previous report, or 4.19% of the shares available to trade. At recent volumes it would take 6.0 days to buy them back. Over the last 20 sessions, 48.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	705,801	+6.3%	118,342	6.0
Oct 15, 2026	663,833	+12.1%	412,805	1.6
Sep 30, 2026	592,420	-4.3%	143,193	4.1
Sep 15, 2026	619,262	-20.9%	110,332	5.6
Aug 31, 2026	782,459	+9.5%	152,693	5.1
Aug 14, 2026	714,471	-40.5%	271,896	2.6
Jul 31, 2026	1,200,354	+67.2%	316,846	3.8
Jul 15, 2026	718,008	+172.4%	399,680	1.8
Jun 30, 2026	263,542	-65.6%	424,964	1.0
Jun 15, 2026	765,484	+231.8%	346,077	2.2
May 29, 2026	230,679	-9.5%	481,407	1.0
May 15, 2026	255,031	-64.0%	1,289,720	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?